Status: Recruiting
FlexiOss® - Efficacy, Safety and Long-term (Radiological and Clinical) Outcomes During Comprehensive Care Continuum of Implanted Biocomposite for Bone Regeneration.
The aim of this clinical study is to evaluate the efficacy, safety and long-term (radiological and clinical) outcomes during comprehensive care continuum of implanted biocomposite for bone regeneration FlexiOss® compared to the current standard of care in patients with primary acute trauma bone defects. The efficacy, safety and long-term (radiological and clinical) evaluation will be assessed during follow up visits at 2, 6 weeks, 3, 6, 12 and 24 months.
Participants needed: 80
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Medical Inventi S.A.Updated: Feb 12, 2026Locations: 2
Eligibility criteria
Age between 18 and 75 years. [+4]
Subject with alcohol dependence syndrome or any history of substance abuse withi... [+9]